Kirkpatrick CM - Search Results

1

The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.

McLeay SC, Morrish GA, Kirkpatrick CM, Green B. McLeay SC, et al. Among authors: kirkpatrick cm. Clin Pharmacokinet. 2012 May 1;51(5):319-30. doi: 10.2165/11598930-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22439649 Review.

2

Principles and clinical application of assessing alterations in renal elimination pathways.

Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ. Tett SE, et al. Among authors: kirkpatrick cm. Clin Pharmacokinet. 2003;42(14):1193-211. doi: 10.2165/00003088-200342140-00002. Clin Pharmacokinet. 2003. PMID: 14606929 Review.

3

A standard weight descriptor for dose adjustment in the obese patient.

Duffull SB, Dooley MJ, Green B, Poole SG, Kirkpatrick CM. Duffull SB, et al. Among authors: kirkpatrick cm. Clin Pharmacokinet. 2004;43(15):1167-78. doi: 10.2165/00003088-200443150-00007. Clin Pharmacokinet. 2004. PMID: 15568893

4

Analysis of population pharmacokinetic data using NONMEM and WinBUGS.

Duffull SB, Kirkpatrick CM, Green B, Holford NH. Duffull SB, et al. Among authors: kirkpatrick cm. J Biopharm Stat. 2005;15(1):53-73. doi: 10.1081/bip-200040824. J Biopharm Stat. 2005. PMID: 15702605

5

Dosing in obesity: a simple solution to a big problem.

Han PY, Duffull SB, Kirkpatrick CM, Green B. Han PY, et al. Among authors: kirkpatrick cm. Clin Pharmacol Ther. 2007 Nov;82(5):505-8. doi: 10.1038/sj.clpt.6100381. Clin Pharmacol Ther. 2007. PMID: 17952107

6

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Hennig S, Norris R, Kirkpatrick CM. Hennig S, et al. Among authors: kirkpatrick cm. Br J Clin Pharmacol. 2008 Apr;65(4):502-10. doi: 10.1111/j.1365-2125.2007.03045.x. Epub 2007 Nov 8. Br J Clin Pharmacol. 2008. PMID: 17995972 Free PMC article.

7

Lean body mass normalizes the effect of obesity on renal function.

Janmahasatian S, Duffull SB, Chagnac A, Kirkpatrick CM, Green B. Janmahasatian S, et al. Among authors: kirkpatrick cm. Br J Clin Pharmacol. 2008 Jun;65(6):964-5. doi: 10.1111/j.1365-2125.2008.03112.x. Epub 2008 Feb 15. Br J Clin Pharmacol. 2008. PMID: 18279477 Free PMC article. No abstract available.

8

Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection.

Roos JF, Kirkpatrick CM, Tett SE, McLachlan AJ, Duffull SB. Roos JF, et al. Among authors: kirkpatrick cm. Br J Clin Pharmacol. 2008 Oct;66(4):455-66. doi: 10.1111/j.1365-2125.2008.03247.x. Epub 2008 Jun 28. Br J Clin Pharmacol. 2008. PMID: 18699833 Free PMC article.

9

Informative study designs to identify true parameter-covariate relationships.

Han PY, Kirkpatrick CM, Green B. Han PY, et al. Among authors: kirkpatrick cm. J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):147-63. doi: 10.1007/s10928-009-9115-y. Epub 2009 Mar 27. J Pharmacokinet Pharmacodyn. 2009. PMID: 19326192

10

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey.

Barras MA, Kirkpatrick CM, Green B. Barras MA, et al. Among authors: kirkpatrick cm. Br J Clin Pharmacol. 2010 May;69(5):520-8. doi: 10.1111/j.1365-2125.2010.03626.x. Br J Clin Pharmacol. 2010. PMID: 20573088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page